BioSpace News Archive

Genetown

Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

Inhibikase Therapeutics, Inc. today announced that Dr. Milton Werner, President and Chief Executive Officer of Inhibikase Therapeutics, will present an update on the of the 201 Trial evaluating risvodetinib (“risvo”) at the 2024 AD/PD Meeting being held March 5-9, 2024 in Lisbon, Portugal.

March 7, 2024
·
5 min read
IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference

IceCure Medical Ltd. today announced that the Company’s Chief Executive Officer, Eyal Shamir , will present at the 34th Annual Oppenheimer Healthcare MedTech & Services Conference on Tuesday, March 12, 2024, at 8:00am EST.

March 7, 2024
·
3 min read
Business

BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that Cristin Hubbard has been named executive vice president and chief commercial officer.

March 7, 2024
·
5 min read
Genetown

BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell

BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell.

March 7, 2024
·
4 min read
Business

Vast Therapeutics Expands Leadership Team with Appointment of Dr. Paul Bruinenberg as Chief Medical Officer

Vast Therapeutics today announced the addition of Paul Bruinenberg , MD, MBA as Chief Medical Officer.

March 7, 2024
·
4 min read
Policy

Champions Oncology’s US Laboratory has Acquired Distinguished CAP Accreditation

Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced that the College of American Pathologists has awarded accreditation to its US-based laboratory.

March 7, 2024
·
2 min read
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development

AB Science SA is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development.

March 7, 2024
·
11 min read
RDS secures CE mark for MultiSense® Remote Patient Monitoring solution

RDS, the medical device start-up, today announces the granting of the CE mark for MultiSense®, its patented, wearable solution for continuous Remote Patient Monitoring.

March 7, 2024
·
4 min read
PumasAI Now Offering its Modeling and Simulation Software Free to Academic Research Institutions

Pumas-AI Inc, a science-first organization that turns data into life-saving decisions faster, announced today that it is now opening its powerful modeling and simulation software to all global academic institutions and researchers free of charge.

March 7, 2024
·
2 min read
Drug Development

Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology

Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease, today announced publication of results in Clinical Gastroenterology and Hepatology from an expansion cohort (Cohort D, N=31) of the Phase 2b SYMMETRY study.

March 7, 2024
·
6 min read